Hybrid Conferencee

International Conference on Neurodegenerative Disorders and Research (ICNDRR - 27)

14th - 15th January 2027 | Doha, Qatar
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Doha. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Doha event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Doha conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Doha, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Doha."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Pathophysiology of Neurodegenerative Disorders

This session will explore the underlying biological mechanisms contributing to neurodegenerative diseases, focusing on cellular and molecular pathways. Emphasis will be placed on the role of neuroinflammation and oxidative stress in the progression of disorders such as Alzheimer's and Parkinson's.

Track 02

Advancements in Alzheimer's Disease Research

This track will highlight recent breakthroughs in the understanding and treatment of Alzheimer's disease. Discussions will include novel biomarkers, therapeutic strategies, and the impact of lifestyle factors on disease progression.

Track 03

Innovative Approaches to Parkinson's Disease Management

This session will focus on cutting-edge research and clinical practices aimed at improving the quality of life for individuals with Parkinson's disease. Topics will include pharmacological advancements, non-pharmacological interventions, and patient-centered care models.

Track 04

Neurobiology of Dementia: Mechanisms and Implications

This track will delve into the neurobiological changes associated with various forms of dementia, including Alzheimer's and vascular dementia. Presentations will cover synaptic dysfunction, neuronal loss, and the implications for therapeutic interventions.

Track 05

Clinical Trials in Neurodegenerative Disorders

This session will provide insights into the design, execution, and outcomes of clinical trials focused on neurodegenerative diseases. Participants will discuss challenges in recruitment, endpoint selection, and regulatory considerations.

Track 06

Neuroprotective Strategies and Therapeutic Approaches

This track will examine potential neuroprotective strategies aimed at slowing the progression of neurodegenerative diseases. Topics will include pharmacological agents, lifestyle modifications, and emerging therapies.

Track 07

Genetic and Environmental Factors in Neurodegeneration

This session will explore the interplay between genetic predispositions and environmental influences in the development of neurodegenerative disorders. Discussions will focus on gene-environment interactions and their implications for prevention and treatment.

Track 08

Neuroimaging Techniques in Neurodegenerative Research

This track will highlight the role of advanced neuroimaging techniques in the study of neurodegenerative disorders. Presentations will cover the use of MRI, PET, and other imaging modalities to assess disease progression and treatment efficacy.

Track 09

Cognitive and Behavioral Aspects of Neurodegenerative Disorders

This session will address the cognitive and behavioral changes associated with neurodegenerative diseases, emphasizing the need for comprehensive assessment and intervention strategies. Topics will include neuropsychological testing and psychosocial support.

Track 10

Translational Research in Neuroscience

This track will focus on the translation of basic neuroscience research into clinical applications for neurodegenerative disorders. Emphasis will be placed on collaborative efforts between researchers and clinicians to bridge the gap between laboratory findings and patient care.

Track 11

Future Directions in Neurodegenerative Disorder Research

This session will explore emerging trends and future directions in the research of neurodegenerative disorders. Discussions will include innovative technologies, interdisciplinary approaches, and the potential for personalized medicine.